The report ' Global Congestive Heart Failure (CHF) Treatment Devices ' Market by Type (Cardiac Resynchronization Therapy (CRT), Implantable Cardioverter Defibrillators (ICDs)), By End-user (Hospitals and clinics, Specialized Cardiovascular Disease Treatment Centers, Ambulatory surgery centres) and By Region (North America, Latin America, Europe, Asia Pacific and the Middle East & Africa). With a market size of USD 16.19 bn in 2020, the Global Congestive Heart Failure (CHF) Treatment Devices Market Size will grow to USD 35.97 bn by 2030 with a CAGR of 8.31 %.
To know more about the report, Click on the link :- https://www.strategicmarketresearch.com/market-report/congestive-heart-failure-treatment-devices-market
Key Factors that are expediting the Market growth
Poor nutrition, a lack of exercise, changing lifestyles, rising stress, unhealthy weight gain, and increased smoking and alcohol consumption are all factors. Furthermore, illnesses such as coronary artery disease, sleep apnea, heart defects, irregular heartbeats, diabetes mellitus, obesity, and kidney problems all contribute to the occurrence of chronic heart failure and have a synergistic effect.
By Product, Implantable Cardioverter Defibrillators (ICDs) have the largest market share.
ICDs are the industry leader because of their numerous applications. The majority of contemporary ICDs may function as a pacemaker as well as a defibrillator. When there is an aberrant heartbeat, many ICDs also record the electrical patterns of the heart. This can assist the doctor in developing a treatment strategy for the future.
By End-User, the Hospital segment is projected to show sheer dominance.
The hospital segment leads the market due to better availability of surgeons, safe practices, and higher efficiencies.
THE REGION NORTH AMERICA IS PREDICTED TO BE THE LARGEST MARKET, FOLLOWED BY EUROPE
North America & Europe are comprehensively leading the market due to the high number of cardiovascular disorders and ageing population.
The Asia-Pacific region was regarded as the fastest Growing Market due to the higher aged population of India and China.
IMPORTANT MARKET PLAYERS:
Some of the leading key players in the Global Congestive Heart Failure (CHF) Treatment Devices Market include -Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, HeartWare International, Inc., Jarvik Heart, Inc., LivaNova PLC, Medtronic plc, ReliantHeart Inc., and St. Jude Medical, Inc.
Recent Developments